Autonomix Medical, Inc. (AMIX)
Nasdaq · Healthcare · Medical Devices
$3.54−6.35%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $6.9M
- 52-week range
- $2.44 – $32.55
- 52-week change
- −84.87%
- EPS (trailing)
- −$39.67
Fiscal year to Mar 2026
- Revenue
- $0K
- Net income
- −$16.7M
- Free cash flow
- −$12.3M
From the company’s annual report on SEC EDGAR.
About Autonomix Medical, Inc.
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Headquarters: The Woodlands, United States · autonomix.com